Abcellera Biologics Inc
ABCL · NASDAQ2.79
2.79
USD-0.21-7.15%Balance Sheet
Total Assets
23.49M
1.01B
Liabilities And Stockholders Equity
23.49M
1.01B
Income Statement
Total Revenue
11.61M
233.16M
Cost Of Revenue
10.11M
27.14M
Gross Profit
1.5M
206.01M
Total Operating Expenses
13.95M
41.66M
Operating Income
-4.12M
156.03M
Income Before Tax
-2.21M
157.83M
Net Income After Taxes
-
118.92M
Net Income Before Extraordinary Items
-
118.92M
Net Income
-2.42M
118.92M
Net Income Applicable To Common Shares
-2.21M
118.92M
Diluted Net Income
-2.21M
118.92M
Diluted Weighted Average Shares
237.72
320.28
Diluted EPS Excluding Extraordinary Items
-
0.37
Diluted Normalized EPS
-0.01
0.37
EBIT
-4.12M
164.34M
Cash Flow
Total Cash From Operating Activities
2.69M
22.69M
Total Cash Flows From Investing Activities
-5.78M
-119.78M
Total Cash From Financing Activities
194.83K
683.65M
Exchange Rate Changes
-
-
Change In Cash
-2.89M
586.56M
Free Cash Flow
-1.3M
8.02M
What are you waiting for?Start making profit today
©
2025
All rights reserved